Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Ingresos
10,442
10,442
10,286
9,685
9,084
7,992
Crecimiento de los Ingresos (YoY)
2%
2%
6%
7%
14%
52%
Costo de los ingresos
6,465
6,465
6,352
6,009
5,625
5,086
Utilidad bruta
3,977
3,977
3,934
3,676
3,459
2,906
Venta, General y Administración
3,140
3,140
2,360
2,177
2,021
1,452
Investigación y Desarrollo
57
57
71
97
81
33
Gastos de Operación
2,984
2,984
3,133
2,871
2,621
1,876
Otras Ingresos (Gastos) No Operativos
-9
-9
-24
6
-452
-99
Ingreso antes de impuestos
772
772
405
339
602
927
Gasto por Impuesto a la Renta
210
210
151
147
119
206
Ingreso Neto
560
560
252
190
480
718
Crecimiento de la Utilidad Neta
122%
122%
33%
-60%
-33%
39%
Acciones en Circulación (Diluidas)
121.86
121.86
121.86
121.86
122.25
119.96
Cambio de Acciones (YoY)
0%
0%
0%
0%
2%
7%
EPS (Diluido)
4.59
4.59
2.06
1.55
3.92
5.99
Crecimiento de EPS
122%
122%
33%
-60%
-34%
30%
Flujo de efectivo libre
1,138
1,138
798
465
627
866
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
38.08%
38.08%
38.24%
37.95%
38.07%
36.36%
Margen de operación
9.5%
9.5%
7.78%
8.31%
9.22%
12.87%
Margen de beneficio
5.36%
5.36%
2.44%
1.96%
5.28%
8.98%
Margen de flujo de caja libre
10.89%
10.89%
7.75%
4.8%
6.9%
10.83%
EBITDA
--
--
1,613
1,724
1,561
1,507
Margen de EBITDA
--
--
15.68%
17.8%
17.18%
18.85%
D&A para EBITDA
--
--
812
919
723
478
EBIT
993
993
801
805
838
1,029
Margen de EBIT
9.5%
9.5%
7.78%
8.31%
9.22%
12.87%
Tasa de Impuesto Efectiva
27.2%
27.2%
37.28%
43.36%
19.76%
22.22%
Follow-Up Questions
AddLife AB'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, AddLife AB'in toplam varlıkları $12,711 olup, net ganancia $560'dir.
ADDLY'ün temel finansal oranları nelerdir?
AddLife AB'in cari oranı 1.74, net kâr marjı 5.36, hisse başına satış $85.68'dir.
AddLife AB'in geliri segment veya coğrafya bazında nasıl dağılıyor?
El segmento de ingresos más grande es AddLife AB, con unos ingresos de MedTech en el último informe de ganancias. En cuanto a la geografía, Other Countries es el mercado principal para AddLife AB, con unos ingresos de 2,914,000,000.
AddLife AB kârlı mı?
sí, son mali tablolara göre AddLife AB'in net ganancia $560'dir.
AddLife AB'in herhangi bir yükümlülüğü var mı?
sí, AddLife AB'in yükümlülüğü 7,268'dir.
AddLife AB'in tedavüldeki hisse sayısı kaçtır?
AddLife AB'in toplam tedavüldeki hisse sayısı 121.86'dir.
Estadísticas clave
Cierre Anterior
--
Precio de apertura
--
Rango del día
-
Rango de 52 semanas
-
Volumen
--
Volumen promedio
--
Rendimiento de dividendos
--
EPS (TTM)
--
Cap. de mercado
--
¿Qué es ADDLY?
AddLife AB engages in the ownership and acquisition of firms in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm and currently employs 2,295 full-time employees. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.